Pterostilbene is reported to reduce NADPH oxidase-dependent superoxide anion production and oxidative stress and prevent right ventricle hypertrophy in monocrotaline-induced pulmonary hypertension of rats [24]. The gene discussed is FMO5; the disease is pulmonary arterial hypertension.